Hsenghung Sam Hsu net worth and biography

Hsenghung Hsu Biography and Net Worth

Director of Fastenal

Mr. Hsenghung Sam Hsu is Executive Vice President of Strategic Planning for Ecolab Inc., a global leader in water, hygiene, and infection prevention solutions and services, headquartered in St. Paul, MN, where he has led corporate strategy and various business initiatives since January 2016. He has held various other positions with Ecolab since 1996, most recently serving as Executive Vice President/Senior Vice President, Global Services Business Sector from 2012 to January 2016. Prior to his service with Ecolab, Mr. Hsu was employed with Merrill Lynch Asset Management and the Ministry of Health in Taiwan, where he was born. His background in global business management, strategic planning, corporate governance, finance, treasury and capital markets, business-to-business sales and marketing, mergers and acquisitions, digital transformation, developing high-performing teams, and new business developments, provides valuable insight and guidance in these areas to the board. Mr. Hsu previously served as chair of the board of directors for the Children’s Theatre Company in Minneapolis, served on the board of directors for the American Composers Forum, served as chair on the Food, Agriculture and Beverage committee for the American Chamber of Commerce in Shanghai, served on the board of directors of the Chinese Institute of Food Science and Technology, and was executive director of the board for the China Health Inspection Association.

Mr. Hsu has been a director of Fastenal since 2020 and is a member of our audit committee.

What is Hsenghung Sam Hsu's net worth?: The estimated net worth of Hsenghung Sam Hsu is at least $202,500.00 as of September 13th, 2021. Mr. Hsu owns 3,000 shares of Fastenal stock worth more than $202,500 as of April 19th. This net worth estimate does not reflect any other investments that Mr. Hsu may own. Learn More about Hsenghung Sam Hsu's net worth.
How do I contact Hsenghung Sam Hsu?: The corporate mailing address for Mr. Hsu and other Fastenal executives is 2001 THEURER BLVD, WINONA MN, 55987. Fastenal can also be reached via phone at (507) 454-5374 and via email at [email protected]. Learn More on Hsenghung Sam Hsu's contact information.
Has Hsenghung Sam Hsu been buying or selling shares of Fastenal?: Hsenghung Sam Hsu has not been actively trading shares of Fastenal during the past quarter. Most recently, on Monday, September 13th, Hsenghung Sam Hsu bought 1,000 shares of Fastenal stock. The stock was acquired at an average cost of $53.20 per share, with a total value of $53,200.00. Following the completion of the transaction, the director now directly owns 3,000 shares of the company's stock, valued at $159,600. Learn More on Hsenghung Sam Hsu's trading history.
Who are Fastenal's active insiders?: Fastenal's insider roster includes Michael Ancius (Director), Anthony Broersma (EVP), Michael Dolan (Director), William Drazkowski (Insider), Stephen Eastman (Director), Daniel Florness (CEO), Leland Hein (VP), Rita Heise (Director), Hsenghung Hsu (Director), James Jansen (EVP), Daniel Johnson (Director), Sheryl Lisowski (CAO), Nicholas Lundquist (Director), Charles Miller (VP), Sarah Nielsen (Director), Willard Oberton (Director), Terry Owen (VP), John Soderberg (VP), Jeffery Watts (Insider), and Reyne Wisecup (VP). Learn More on Fastenal's active insiders.
Are insiders buying or selling shares of Fastenal?: In the last twelve months, Fastenal insiders bought shares 2 times. They purchased a total of 3,850 shares worth more than $257,838.00. In the last twelve months, insiders at the sold shares 17 times. They sold a total of 293,808 shares worth more than $18,415,858.62. The most recent insider tranaction occured on April, 17th when Director Daniel L Johnson bought 3,350 shares worth more than $229,073.00. Insiders at Fastenal own 0.4% of the company. Learn More about insider trades at Fastenal.
Information on this page was last updated on 4/17/2024.

Hsenghung Sam Hsu Insider Trading History at Fastenal

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/13/2021	Buy	1,000	$53.20	$53,200.00	3,000
10/19/2020	Buy	2,000	$44.75	$89,500.00	1,000
10/16/2020	Buy	1,000	$45.00	$45,000.00	1,000

Hsenghung Sam Hsu Buying and Selling Activity at Fastenal

Fastenal Company Overview

Fastenal Company, together with its subsidiaries, engages in the wholesale distribution of industrial and construction supplies in the United States, Canada, Mexico, North America, and internationally. It offers fasteners, and related industrial and construction supplies under the Fastenal name. The company's fastener products include threaded fasteners, bolts, nuts, screws, studs, and related washers that are used in manufactured products and construction projects, as well as in the maintenance and repair of machines. It also offers miscellaneous supplies and hardware, including pins, machinery keys, concrete anchors, metal framing systems, wire ropes, strut products, rivets, and related accessories. The company serves the manufacturing market comprising original equipment manufacturers; maintenance, repair, and operations customers; non-residential construction market; farmers, truckers, railroads, mining companies, schools, and retail trades; and oil exploration, production, and refinement companies, as well as federal, state, and local governmental entities. Fastenal Company was founded in 1967 and is headquartered in Winona, Minnesota.

Today's Range

Now: $67.50

$67.38

$68.99

50 Day Range

MA: $73.67

$67.50

$78.42

2 Week Range

Now: $67.50

$52.28

$79.04

Volume

3,583,476 shs

Average Volume

3,814,300 shs

Market Capitalization

$38.65 billion

P/E Ratio

33.42

Dividend Yield

2.28%

Beta

1.05

Healthcare Takes A Big Step Forward With The Help Of AI

From The Bull Report | Ad

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic